All In Biotech

Drug Trial Radar · NCT01379664

Volatile Anesthetic Choice and Duration of Hospitalization: A Quality Improvement and Cost-control Project

Last checked: Nov 20, 2026Latest source record: Apr 10, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

1,584

Actual

Start

Jul 2011

Primary completion

Apr 2013

Study completion Apr 2013

Sponsor

Lead sponsor
The Cleveland ClinicAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 23, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Health services research
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Preliminary retrospective data suggest that the relatively soluble but inexpensive volatile anesthesia isoflurane prolongs the duration of hospitalization compared to the less soluble but more expensive anesthetic sevoflurane. Even a small reduction in the duration of hospitalization would easily compensate for the modest additional cost of sevoflurane. The investigators therefore propose to test the primary hypothesis that duration of hospitalization is longer with isoflurane than sevoflurane. The investigators will also test the secondary hypotheses that: 1) pain scores are greater in patients recovering from isoflurane than sevoflurane anesthesia; and, 2) opioid consumption is greater after isoflurane than sevoflurane anesthesia. All statistical analyses will be adjusted for age, gender, race, baseline risk, 9 and procedure.

Conditions

  • Duration of Hospitalization

Interventions

  • IsofluraneDrug

    Isoflurane is administered to patient during surgery as it would normally be administered by the attending anesthesiologist

  • SevofluraneDrug

    Sevoflurane is administered to patient during surgery as it would normally be administered by the attending anesthesiologist

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Hospital Length of StayTime frame: participants will be followed for the duration of hospital stay, an expected average of 3 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Cleveland Clinic

    Cleveland, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.